ProteanFect Transfection Kit ----- by AURORABOH INC 👉 Inquiries: Contact us at aurorabohsales@gmail.com				Product PDF version
	Product	Applicable cell line	Cat#	Volume
	ProteanFect Transfection Kit	Hard-to-transfect cell lines	PT01	0.1, 0.3, 0.5, 1.0, 5.0 mL
	ProteanFect Max Transfection Kit	Challenging primary cells and hard-to-transfect cell line	PT02	0.1, 0.3, 0.5, 1.0, 5.0 mL
	ProteanFect Max Mouse Immunocyte Transfection Kit	Primary Mouse Immunocytes	PT03	0.1, 0.3, 0.5, 1.0, 5.0 mL
	ProteanFect CRISPR Transfection Kit	Hard-to-transfect cell lines	PT04	0.1, 0.3, 0.5, 1.0, 5.0 mL
	ProteanFect CRISPRMax Transfection Kit	Challenging primary cells and hard-to-transfect cell line	PT05	0.1, 0.3, 0.5, 1.0, 5.0 mL
	ProteanFect CRISPRMax Mouse Immunocyte Transfection Kit	Primary Mouse Immunocytes	PT06	0.1, 0.3, 0.5, 1.0, 5.0 mL

Experience the next generation of nucleic acid delivery with ProteanFect™, the world's first coacervate-based gene delivery system. Designed for today's most demanding research challenges, ProteanFect™ offers a non-viral, non-electroporation, and non-liposomal solution for efficient transfection, especially in difficult primary cells like T cells, NK cells, and hematopoietic stem cells.

Key Features:

• High Transfection Efficiency:
  Achieves superior delivery of mRNA into human primary T cells, NK cells, mouse primary T cells, and human CD34+ hematopoietic stem cells — all with minimal toxicity.
• Enhanced Cell Viability:
  Demonstrates higher cell viability compared to traditional electroporation methods, preserving the natural differentiation potential of sensitive cells.
• Powerful Gene Expression:
  ProteanFect™ enables more copies of nucleic acids to be delivered per cell, resulting in significantly stronger gene expression compared to liposomal nanoparticles (LNPs) and electroporation techniques.
• Rapid and Safe Delivery:
  Coacervate-formed nanoparticles swiftly deliver cargo into cells and safely degrade post-delivery, ensuring clean experimental outcomes.

Proven Performance:

• Achieves 59.5% GFP+ expression in primary T cells with higher mean fluorescence intensity compared to electroporation.
• Maintains cell viability around 80%, significantly better than traditional methods.

---

ProteanFect™ is your reliable and innovative solution for primary cell transfection — redefining what’s possible in gene therapy, cell engineering, and advanced research.